Abstract
No public abstract is available from the verified source records.
Valeriya Kuznetsova, Rishi K. Kothuru, Prasad S. Adusumilli, Alfredo Amador-Molina
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
10.1038/s41375-018-0065-5 · 2018
IL7-receptor-targeted CAR T-cell therapy for T-cell acute lymphoblastic leukemia
10.1038/s41467-026-75675-5 · 2026
Overexpression of wild-type IL-7Ralpha promotes T-cell acute lymphoblastic leukemia/lymphoma
10.1182/blood.2019000553 · 2021
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition
2023
Tumor antigen escape from CAR T-cell therapy
10.1158/2159-8290.cd-18-0442 · 2018
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape
10.1038/s41392-022-00898-z · 2022
Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling
10.4049/jimmunol.180.8.5201 · 2008
Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice
10.1158/0008-5472.can-15-0159 · 2015
CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
10.1186/s13045-021-01178-z · 2021
Universal base-edited CAR7 T cells for T-cell acute lymphoblastic leukemia
10.1056/nejmoa2505478 · 2026
No additional external references are available.